BD Alaris™ neXus PK Syringe Pump 

Trusted. Connected. Improved*

Timely, precise and effective administration of anaesthesia¹

During complex operating room (OR) procedures, patient safety is a concern.

The BD Alaris™ neXus PK Syringe Pump offers a broad range of plasma Pharmacokinetics (PK) and effect site Pharmacodynamic (PD) targeting models.¹ Suitable for all ages and body compositions, including bariatric patients,¹ helping Anaesthetists meet IV anaesthesia requirements in a timely and accurate way.²

Now with:

• Eleveld Propofol TCI
• Eleveld Remifentanil TCI
• Kim-Obara-Egan Remifentanil TCI
• Hannivoort - Colin Dexmedetomidine TCI

Medication safety

BD Alaris™ neXus PK Syringe Pump will be provided with a default ANZ data set which contains Eleveld, Kim-Obara, and Hannivoort TCI models.  

BD Medication Safety consultants are available to support hospitals with editor software training and dataset changes upon request. Get in touch with our BD Guardrails™ Support team by clicking on the button below.

Wi-Fi enabled BD Alaris™ neXus PK Syringe Pumps allow for wireless dataset upload without interrupting clinical workflows.¹

Device integration

Accurate and timely capture of infusion status data supports clinical workflow. Transcription errors and delays in data entry can result in incorrect treatment and possible patient harm.³

BD is excited to announce integration partnerships with number of Australian, New Zealand and globally based healthcare IT vendors that will enable seamless, automated documentation of infusion data from the BD Alaris™ neXus Infusion Pump platform into the Anaesthesia Information Management System (AIMS).

The project will replace the need for manual recording of infusion information currently associated with Total Intravenous Anaesthesia (TIVA), by integrating infusion data from the infusion pump directly into the AIMS in near real time.

This design enhancement supports the automatic creation of clinically accurate, detailed data into an electronic medical record, reducing duplicate entry, manual data entry errors and administrative recording which collectively enhances optimal patient care. Please see 'Additional Resources' section for existing integration partnerships.

For any further queries, please contact BD by clicking on the button below.

Maintenance of anaesthesia using total intravenous anaesthesia (TIVA) with target-controlled infusion (TCI) is well-established in clinical practice and has several potential advantages over inhaled volatile anaesthesia⁴. The development of novel TCI models allows you to achieve anaesthetic precision in patients with a range of ages and weights⁵.

New models for TCI - meet the developers!

In this webinar, the scientists who created the Eleveld models explained how they developed these models and why they are a game-changer for TCI.

Prof. Dr. Michel M. R. F. Struys
Dr. Laura N. Hannivoort
Dr. Douglas J. Eleveld
University Medical Center Groningen, The Netherlands

Designed by anaesthetists for anaesthetists

BD offers anaesthetists, a comprehensive range of solutions that can help:

• Enhance clinical outcomes⁶
• Promote patient safety⁷
• Increase medication safety⁷
• Improve workflow efficiency⁶
• Optimise inventory management⁸

BD Alaris™ neXus PK Syringe Pump

Latest TCI drug models

• Propofol (Eleveld)
• Remifentanil (Eleveld)
• Dexmedetomidine (Hannivoort-Colin)
• Remifentanil (Kim-Obara-Egan) (for bariatric patients)

Patient safety features

• Easily differentiate between anaesthetic drugs when a pump is programmed¹
• Patented technology: automatic weight-height default parameter adjustment based on the patient's age¹

Simplified drug setup

• With a user-friendly interface and large display showing all critical infusion data at a glance¹
• Unique visual identification of propofol¹

Click on the image above to access the BD Alaris neXus PK video

BD Alaris™ neXus Solution

Help to simplify the infusion experience through connectivity solutions. Wi-Fi enabled IV medication safety systems for all care areas in hospitals:

• Designed to help prevent medications errors⁷
• Whilst simplifying the process to release time for care and improve workflow efficiency⁶

With the overall BD Alaris™ neXus Infusion Solutions and BD Alaris™ Communication Engine (ACE), you can benefit from:

• Automated transfer of datasets to pumps over the hospital network during infusion⁹
• Continuous collection of pump log events and continuous quality improvement (CQI) data⁹
• Remote and central visualisation of infusions and asset management (asset tracking)⁹
• Infusion data documentation into patient data management system flow sheets⁹

BD Alaris™ Guardrails™ Safety Software

Our BD Alaris™ neXus Pumps use unique BD Alaris™ Guardrails™ Safety Software, which provides safety limits for each drug by care area, promoting safe delivery of IV medication.¹⁰

It can help reduce IV medication errors, improve the overall quality of patient care,¹⁰ track and measure system performance and help increase compliance with national safety standards. It can help you deliver the right medicine with the right dose at the right concentration for safe medication management and administration.

With BD Alaris™ neXus Solutions we are addressing your key concerns when it comes to IV administration.

BD TIVA Administration Sets

Specifically designed for use with TCI pumps, these sets help ensure the patient receives:

• A more predictable onset of drugs
• Greater accuracy and ease of maintenance
• A more predictable offset of drugs

Additional resources

BD and SAFERsleep customer communication

BD and Getz Clinical customer communication

Let's have a conversation

The BD Alaris™ neXus PK Syringe Pump is intended for use by medical staff for purposes of controlling infusion rate and volume.

Please read the respective product Instructions for Use for additional safety information, including Contraindications, Warnings, and Precautions.

References: 

1.1. BD Alaris™ neXus PK Syringe Pump Directions for use
2. Wrong-Record, Wrong-Data Errors with Health IT Systems. PSO Navigator. 2015;7(2):1-10.
3. Chang L, Luo Q, Chai Y, Shu H. Accidental awareness while under general anaesthesia. Biosci Trends. 2019;13(4):364-366. doi:10.5582/bst.2019.01237
4. Wong GTC, Choi SW, Tran DH, Kulkarni H, Irwin MG. An international survey evaluating factors influencing the use of total intravenous anaesthesia. Anaesth Intensive Care. 2018;46(3)
5. Hannivoort LN, Eleveld DJ, Proost JH, et al. Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers.
Anesthesiology. 2015;123(2):357-67. doi: 10.1097/ALN.0000000000000740
6. Miller TE, Gan TJ. Total intravenous anesthesia and anesthetic outcomes. J Cardiothorac Vasc Anesth. 2015;29 Suppl 1:S11-15. doi:10.1053/j.jvca.2015.01.022
7. Sepúlveda V, Lobo, FA. A Comparison of Inhaled Anesthesia and Total Intravenous Anesthesia with Target-Controlled Infusion for Neuroanesthesia. In: Brambrink A, Kirsch J, eds. Essentials of
Neurosurgical Anesthesia & Critical Care, 2nd ed. Springer, Cham; 2020.
https://doi.org/10.1007/978-3-030-17410-1_19
8. Lee DJ, Ding J, Guzzo TJ. Improving Operating Room Efficiency. Curr Urol Rep. 2019;20(6):28. doi:10.1007/s11934-019-0895-3
9. BD Alaris Communication Engine V2.0 User Guide 2020: 1 - 109.
10. BD Alaris System with Guardrails Suite MX V12.1.1 User Manual 2021: 1 - 382.

*Compared to BD Alaris™ Plus PK Syringe Pump Target Controlled Infusion (TCI). Please consult the Directions for Use for individual model parameters.

Becton Dickinson Pty Ltd, Australia Toll Free: 1800 656 100 

Becton Dickinson Limited, New Zealand Toll Free: 0800 572 468

BD, the BD logo, Alaris and Guardrails are trademarks of Becton, Dickinson and Company or its affiliates. All other trademarks are the property of their respective owners.

© 2024 BD. All rights reserved. BD-102471

Terms of Use | Privacy Policy